Jason Russell Chambers, Director at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT), sold 1,172 shares at $6.50 ($8K) on 2015-06-11, disclosed to the SEC on 2015-06-16.
Open-market sale of $8k HRT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.70 | 150 | $1K | 13.0% |
| 2 | $6.60 | 900 | $6K | 76.7% |
| 3 | $6.60 | 21 | $139 | 1.8% |
| 4 | $6.50 | 1 | $7 | 0.1% |
| 5 | $6.50 | 100 | $650 | 8.4% |
| Total | $6.60 avg | 1,172 |
| $8K |
| 100% |
| Filing → |
| HRT | SELL | 2014-08-14 | $37K | — | Filing → |
| HRT | BUY | 2008-09-16 | $32K | — | Filing → |
| HRT | BUY | 2008-09-15 | $4K | — | Filing → |